TrialCancer biomarkers : section A of Disease markers2017

Predictors for the efficacy of Endostar combined with neoadjuvant chemotherapy for stage IIIA (N2) NSCLC.

Xiaoliang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.